Cofounders Capital

Cofounders Capital is a venture capital firm established in 2015, primarily focused on early-stage and seed-stage investments in B2B software companies. The firm is particularly active in the Southeast United States, with a strong emphasis on opportunities within North Carolina. They aim to be the first institutional investors in their portfolio companies, providing not only capital but also hands-on support in areas such as fundraising, hiring, and sales. The firm's investment strategy centers on fostering innovation and driving entrepreneurial success by partnering with visionary founders to build groundbreaking companies.

The firm was co-founded by David Gardner, who serves as a Founding Partner and Managing Director, alongside Managing Partner Tim McLoughlin and Partner Tobi Walter. The team is comprised of former entrepreneurs and operators, bringing a wealth of practical experience to their investment approach. They are recognized for their active role in the North Carolina startup ecosystem, having been acknowledged as the “Most Active Investor” in the region for several years. Cofounders Capital emphasizes a collaborative approach, working closely with entrepreneurs from pre-revenue stages through to profitability.

Cofounders Capital targets a diverse range of sectors within the B2B software landscape, including high-growth SaaS platforms, industry-defining software solutions, dynamic marketplaces, and groundbreaking enterprise software ventures. Their portfolio also extends to business services, healthcare, education, and financial services. Notable investments include companies like Adwerx, Irys, EcoMap, Reveal Mobile, Urban Offsets, Titl, Cycle Labs, Map My Customers, EasyVote Solutions, and ParkMyCloud. The firm manages multiple funds, with Fund III having a target of $50 million and having raised over $46 million to date, planning to invest in 15-20 seed-stage B2B software companies.

The firm provides comprehensive support at every stage of the startup journey, leveraging its extensive network to assist portfolio companies with recruiting talent, securing customers, and attracting further investment. They typically write checks between $300,000 and $1 million for early-stage companies, ranging from the idea or patent stage to those with early revenue. Cofounders Capital explicitly states that they do not invest in hardware, medical devices, or life sciences, maintaining a clear focus on software-driven innovation.